Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.

Adv Healthc Mater · 2025 · PMC11834378 · PMID 39205539

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

EO771 cell viability showed a trend similar to A549 (Figure S8 , Supporting Information), possibly indicating greater resistance to the SeNPs treatment than 4T1 cells.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.